| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P. | 17% | $163,630,594 | 46,093,125 | Robert Nelsen | 30 Sep 2025 | |||
| BlackRock, Inc. | 5.1% | +4% | $55,528,247 | +$10,647,588 | 13,643,304 | +24% | BlackRock, Inc. | 31 Dec 2025 |
| VANGUARD GROUP INC | 4.8% | $19,023,535 | 10,747,760 | The Vanguard Group | 31 Dec 2024 |
As of 31 Dec 2025, 199 institutional investors reported holding 159,015,530 shares of Sana Biotechnology, Inc. - Common Stock (SANA). This represents 59% of the company’s total 267,515,765 outstanding shares.
The largest institutional shareholders of Sana Biotechnology, Inc. - Common Stock (SANA) together control 54% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 14% | 37,430,284 | -0% | 0.01% | $152,341,256 |
| Flagship Pioneering, LLC | 9.3% | 25,001,856 | 0% | 31% | $101,757,555 |
| BlackRock, Inc. | 5.3% | 14,223,527 | +27% | 0% | $57,889,754 |
| VANGUARD GROUP INC | 3.9% | 10,455,195 | +15% | 0% | $42,552,645 |
| CANADA PENSION PLAN INVESTMENT BOARD | 3.8% | 10,242,100 | +0.66% | 0.03% | $41,685,347 |
| STATE STREET CORP | 3% | 8,054,841 | +21% | 0% | $32,783,203 |
| BAILLIE GIFFORD & CO | 2.5% | 6,609,065 | -42% | 0.02% | $26,898,895 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 4,118,138 | +20% | 0% | $16,763,171 |
| Marex Group plc | 1.4% | 3,732,780 | -2.4% | 0.16% | $15,192,415 |
| Integral Health Asset Management, LLC | 1.1% | 3,000,000 | +50% | 0.62% | $12,210,000 |
| Alphabet Inc. | 1.1% | 2,812,500 | 0% | 0.44% | $11,446,875 |
| RENAISSANCE TECHNOLOGIES LLC | 0.63% | 1,691,116 | -15% | 0.01% | $6,882,842 |
| Balyasny Asset Management L.P. | 0.63% | 1,679,130 | 0.01% | $6,834,059 | |
| TWO SIGMA INVESTMENTS, LP | 0.59% | 1,579,705 | +159% | 0.01% | $6,429,399 |
| GOLDMAN SACHS GROUP INC | 0.56% | 1,488,377 | +118% | 0% | $6,057,694 |
| NORTHERN TRUST CORP | 0.53% | 1,407,699 | +6.8% | 0% | $5,729,336 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.52% | 1,399,335 | +10% | 0% | $5,695,293 |
| Woodline Partners LP | 0.49% | 1,317,641 | -4.4% | 0.02% | $5,362,799 |
| MORGAN STANLEY | 0.48% | 1,285,045 | +47% | 0% | $5,230,133 |
| Crestline Management, LP | 0.46% | 1,220,937 | -33% | 9.3% | $4,969,214 |
| BANK OF AMERICA CORP /DE/ | 0.44% | 1,186,251 | +29% | 0% | $4,828,041 |
| UBS Group AG | 0.44% | 1,182,958 | -18% | 0% | $4,814,639 |
| AQR CAPITAL MANAGEMENT LLC | 0.42% | 1,134,324 | -4% | 0% | $4,616,700 |
| Omega Fund Management, LLC | 0.32% | 843,750 | 0% | 1.2% | $3,434,063 |
| JPMORGAN CHASE & CO | 0.3% | 815,455 | -62% | 0% | $3,318,902 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 159,015,530 | $647,213,228 | -$17,817,475 | $4.07 | 199 |
| 2025 Q3 | 163,611,333 | $580,833,656 | +$66,171,035 | $3.55 | 176 |
| 2025 Q2 | 145,417,350 | $397,022,759 | -$12,602,331 | $2.73 | 152 |
| 2025 Q1 | 149,116,670 | $250,510,959 | -$14,520,086 | $1.68 | 156 |
| 2024 Q4 | 157,928,176 | $257,417,788 | -$2,121,232 | $1.63 | 159 |
| 2024 Q3 | 153,260,123 | $637,634,346 | +$16,640,858 | $4.16 | 150 |
| 2024 Q2 | 148,167,660 | $809,021,070 | +$44,986 | $5.46 | 144 |
| 2024 Q1 | 146,274,865 | $1,462,752,586 | +$233,741,262 | $10.00 | 151 |
| 2023 Q4 | 124,526,898 | $508,113,977 | -$12,215,240 | $4.08 | 128 |
| 2023 Q3 | 127,513,989 | $493,495,510 | -$30,211,194 | $3.87 | 132 |
| 2023 Q2 | 134,904,538 | $804,023,148 | +$26,527,612 | $5.96 | 121 |
| 2023 Q1 | 130,716,654 | $427,414,965 | +$6,519,444 | $3.27 | 118 |
| 2022 Q4 | 128,403,041 | $507,152,945 | -$769,516 | $3.95 | 119 |
| 2022 Q3 | 128,339,963 | $769,886,255 | +$13,983,486 | $6.00 | 122 |
| 2022 Q2 | 125,590,881 | $807,500,039 | +$40,235,857 | $6.43 | 111 |
| 2022 Q1 | 119,405,403 | $985,831,531 | +$36,653,787 | $8.26 | 109 |
| 2021 Q4 | 111,562,858 | $1,727,117,718 | +$20,231,159 | $15.48 | 101 |
| 2021 Q3 | 75,725,736 | $1,706,389,522 | +$266,392,448 | $22.52 | 85 |
| 2021 Q2 | 64,059,346 | $1,259,281,145 | +$104,914,051 | $19.66 | 78 |
| 2021 Q1 | 58,277,829 | $1,950,553,711 | +$1,950,553,686 | $33.47 | 74 |